Reimagining how healthcare data is analyzed, this platform enables advanced data science without moving a single byte of patient data. Designed from the ground up to comply with global privacy regulations, it allows hospitals and research institutions to develop powerful AI models using real-world clinical data—while keeping that data entirely on-site under governance. Powered by proprietary federated learning and a modular AI/ML development toolkit, the platform solves one of healthcare’s biggest bottlenecks: secure access to data for innovation. With seamless integration into existing IT systems and end-to-end compliance with GDPR and HIPAA, this is the infrastructure for the future of privacy-first, multi-institutional healthcare data analytics and AI/ML. The technology owner is actively seeking collaboration with healthcare providers, research institutions, clinical research organizations, and data-centric health-tech companies eager to scale innovation—without compromising privacy or control.

Early detection of Mild Cognitive Impairment (MCI), especially the vascular subtype, is becoming increasingly important as populations age and the burden of dementia rises globally. Approximately 12% to 18% of people age 60 or older are living with MCI, and an estimated 10% to 15% of individuals living with MCI develop dementia each year — many of which could benefit from timely intervention to slow or prevent further cognitive decline. This digital solution offers a non-invasive, self-administered cognitive screening tool that can be completed in just 15 minutes via a mobile device or tablet. It uses a series of interactive, neuroscience-informed digital tasks to assess multiple cognitive functions, including working memory, attention, processing speed, and executive function. These areas are particularly relevant in identifying different subtypes of MCI, such as those related to vascular causes. The system’s proprietary algorithm analyzes the user’s performance and has been clinically validated in Southeast Asia, achieving 89% accuracy with strong specificity and sensitivity. Its objective, performance-based design makes it suitable for deployment across various healthcare settings—from hospitals and clinics to insurers and community screening programs. By offering a quick, engaging, and scalable method for cognitive screening, this solution supports earlier identification of cognitive changes and provides actionable insights that can help guide appropriate follow-up care based on the individual’s cognitive profile.

In a world where consumers expect fast, intuitive, and personalised interactions, traditional phone-based customer service systems often fall short—plagued by long wait times, clunky menus, and impersonal scripts. This Generative Voice AI technology offers a transformative alternative: highly localised, low-latency AI Voice Agents that communicate with human-like fluency, adapted to regional languages and accents including Singlish, Mandarin, Bahasa, and Malay. Built on a proprietary orchestration layer that integrates multiple advanced AI models—such as speech recognition, large language models, and natural speech synthesis—this solution delivers seamless, real-time voice interactions with remarkable accuracy and responsiveness. Not only can Voice AI Agents reduce call wait times to zero and improve customer satisfaction for companies, it can also do outbound sales and lead qualification to generate higher revenue. Beyond traditional roles, these Voice AI Agents are also redefining interactive experiences across industries. Imagine a multilingual guide replacing static audio tours in museums and travel hotspots, or a virtual assistant enhancing patient navigation in healthcare settings. In gaming, they enable real-time, unscripted conversations with non-player characters (NPCs), adding depth and realism to gameplay and storytelling. These are not just voice interfaces—they're intelligent conversational agents. The tech owner seeks industry partners and system integrators to embed their proprietary technology into pre-existing software to add value and transform customer experience in sectors such as F&B, Healthcare, Marketing, Tourism, E-Commerce, Hospitality, Insurance, Financial Services, Gaming etc.

This novel technology introduces a breakthrough self-assembly porous hydrogel platform that revolutionizes drug delivery, going far beyond the limitations of traditional static creams and non-porous emulsions. The unique porous hydrogel structure demonstrates an 85% increase in drug bioavailability through enhanced penetration and controlled release, compared to traditional formulations that create impermeable barriers. The innovative one-step drug delivery system achieves a 20-fold reduction in manufacturing costs by eliminating multiple complex steps typically required in conventional processes, such as vehicle manufacturing, formulation and purification. Through its distinctive porous architecture, this streamlined approach delivers enhanced therapeutic outcomes while maintaining production efficiency. Especially on eczema, this technology represents a breakthrough in treatment by addressing the multifactorial nature of the disease. Traditional eczema therapies typically target only one or two aspects of the condition, often leading to limited efficacy and undesirable side effects. In contrast, this delivery method enables the simultaneous modulation of several key pathological pathways. It specifically targets inflammation, oxidative stress, proteasome dysfunction, and ferroptosis while also enhancing skin barrier function—critical factors in both the onset and persistence of eczema. This potentially reduces flare-ups and improves overall skin health. This technology is applicable as an over-the-counter advanced topical formulation and as injectables. The technology provider is seeking the following collaborations: Co-development opportunities Patient centric non-profit organisations to support life-changing treatments. Dermatology focused clinics Formulation focused CRO/CDMO working on complex medicines Startup companies working on new modalities or novel API including oligo medicines AI/ML-driven drug discovery firms. Leverage predictive modeling to optimize key properties, such as porosity and drug loading ratios

This technology represents an innovative approach to indoor air quality (IAQ) management, focusing on sustainability and energy efficiency. Leveraging the principle of dilution, outdoor airflow can be adjusted dynamically to balance energy consumption and air quality. The system uses a predefined control algorithm to determine the optimal mix of outdoor and recirculated air based on the concentration of particulate matter or carbon dioxide in the indoor environment. Users can customise the system's operation based on their IAQ requirements, ensuring efficient ventilation while minimising energy usage. This low-cost solution aims to tackle challenges associated with IAQ, energy efficiency, and sustainability that cannot be accomplished by traditional heating, ventilation, and air conditioning (HVAC) systems. Instead, integrating decentralised air purification technologies into building design and urban planning initiatives, indoor pollutants can be removed while minimising operational costs and environmental impact. City planners can now better prioritise IAQ and energy efficiency from the outset, ensuring that future developments contribute to healthier, more livable communities. Public health, well-being, environmental sustainability, and climate resilience can be strengthened. This technology is best suited for retrofitting air conditioning systems in small to medium-sized residential care facilities and commercial buildings.

This advanced AI art creation platform offers an efficient and accessible solution for generating high-quality digital artwork. Developed with the needs of artists, designers, and content creators in mind, the platform streamlines the creative process through key features such as text-to-image, image-to-image, text-to-video, and conditional image generation. By integrating state-of-the-art AI models with a user-friendly interface, it enables users to produce professional-grade visual content without the need for extensive technical expertise.

Globally, the average daily salt intake is 10.8g—more than twice the WHO’s recommended limit—leading to widespread health issues. In Singapore, 90% of residents consume nearly double the recommended sodium intake, contributing to prevalent health concerns like hypertension and dyslipidemia. Reducing sodium intake is a cost-effective way to enhance public health. However, simply lowering salt content arbitrarily can result in an unacceptably bland taste and compromised flavor stability. Potassium chloride (KCl) is commonly used as a salt substitute, but it has a bitter aftertaste and poses potential health risks, particularly for individuals with kidney disease or those on specific medications. This technology aims to reduce sodium intake with a natural rice umami extract, developed using advanced sodium reduction technology without MSG or alternatives(KCI). This innovative approach amplifies the salty taste sensation, and ensures the natural umami of rice is extracted to its fullest potential. As a result, this technology not only enhances flavor delivery but also promotes healthier consumption by reducing sodium intake without compromising taste.

Facing the dual challenge of high energy consumption and the need for effective air purification in urban environments, this solution optimizes air filtration in HVAC systems. By employing advanced sound wave technology, the specialized emitter agglomerates fine airborne particles, making them easier to capture and significantly reducing the pressure drop across air handling units. This method not only lowers energy usage but also extends filter lifespan, cutting operational costs and maintenance needs. Ideal for building operators and industries that prioritize energy efficiency and superior indoor air quality, such as commercial real estate, hospitals, and manufacturing facilities, this system meets stringent G4 filtration standards and achieves performance levels equivalent to MERV 13 and MERV 14 filters.  The technology presents a cost-effective solution that significantly enhances HVAC performance and air quality, positioning itself as a sustainable investment for facilities dedicated to optimizing operational efficiency and environmental health. It improves motor energy consumption by up to 45%, while also enhancing air quality and reducing operational costs in HVAC systems. The technology owner is actively seeking collaboration partners for research and development, as well as opportunities for test-bedding within the HVAC systems field to enhance indoor air quality.

With the focus on food security and sustainability, urban farming is gaining traction in Singapore. Most farmers who are new to the industry still rely heavily on pesticides for pest control and crop protection. Although effective, the use of pesticides pose several concerns such as: Health and Environmental Risks: Pesticide residues in food pose potential health hazards, while excessive use can lead to soil degradation, water contamination, and harm to beneficial insects and biodiversity. Regulatory and Market Pressure: Stricter regulations on pesticide use and growing demand for organic and naturally grown produce create the need for sustainable solutions. In addition, the educated consumers increasingly prefer pesticide-free vegetables, thereby driving the need for natural alternatives. Biological solutions such as biofertilizers, bionutrients, and biostimulants offer a promising alternative to agriculture. These solutions can: Enhance Plant Growth: Improve nutrient uptake and plant resilience through naturally derived growth stimulants. Improve Soil Health: Support microbial activity and enhance soil fertility without chemical degradation. Reduce Dependence on Chemical Fertilizers and Pesticides: Provide natural pest resistance and nutrient supply. Promote Sustainable Production of Asian Leafy Greens: Crops such as bak choy, butterhead lettuce, and spinach Farmers are seeking to collaborate with companies with biological solutions to run validation trials in their farms.

Agricultural activities in Asia Pacific region generate significant amounts of manure from various farming operations, including: Layer Hens: A layer hen produces approximately 0.08–0.12 kg of manure per day. Cattle Farming: Dairy and beef cattle generate an average of 30 kg of manure per day per animal. Pig Farms: Pigs produce about 2–4 kg of manure per day. Manure accumulation presents several environmental and operational challenges such as odour pollution, water contamination, greenhouse gas emissions and pathogen proliferation. Despite these challenges, manure has significant potential when processed effectively. It can be converted into valuable resources such as: Biogas & Bioenergy Biochar & Carbon Sequestration Organic Fertilizers and Soil Conditioners Farms have found solutions that produce good quality fertilisers and soil conditioners with their manure. However the amount of manure generated is more than what they can use and would like to work with innovation technologies to manage and convert their farm's manure efficiently. 

According to the Health Promotion Board (HPB) in Singapore, 90% of Singapore residents' consumption of sodium exceeds the daily recommended intake, with the average consumption at 3620 mg, nearly double of the recommended 2000 mg per day. As a result, one in six Singapore residents report health problems like hypertension and hypolipidaemia. In an effort to curb this, HPB launched the "Less Salt, More Taste" campaign in 2024 to encourage the food manufacturing and food service industry to change their recipes and add less salt and sauces, or switch to use lower-sodium alternatives for salt, sauces and seasonings. Manufacturers are also encouraged to increase the supply of lower-sodium ingredients for the food service sector. Consumers are also encouraged to choose low sodium options, or use less salt in their home cooking. This sodium reduction strategy aims to reduce Singaporeans’ sodium intake by 15% by 2026.